Pipeline

bonus 1a

Pipeline new55

Pipeline new55

Bonus Biogroup is developing investigational cell therapy and tissue engineering solutions to address conditions involving tissue damage, bone loss, and inflammation. Our proprietary technology platform supports the clinical development of BonoFill and MesenCure, which are currently undergoing evaluation in clinical studies. BonoFill is being investigated as a patient-specific viable bone graft for maxillofacial, dental, and orthopedic applications. MesenCure is being studied as an allogeneic cell therapy for respiratory distress and other inflammatory conditions. Additional research is ongoing to explore new therapeutic indications.

bonus 1a

Image

CELL THERAPY

Our cell therapies are designed to leverage the natural properties of mesenchymal cells and provide multi-functional therapeutic mechanisms to modulate inflammation and promote tissue repair. These therapies are currently being evaluated in clinical trials.

Image

TISSUE ENGINEERING

Our tissue-engineered bone graft is designed to address the limitations of existing bone regeneration and reconstruction therapies. It combines autologous mesenchymal cells with a three-dimensional biocompatible and bioactive mineral scaffold and is intended to be tailored to each patient’s unique biological, physical, and clinical needs.

The product candidates mentioned on this website are in the investigational stage and have not been approved by the FDA or any other regulatory authority for commercial use.

Clinical trials are ongoing to evaluate their safety and efficacy.

INFORMATION FOR INVESTORS  |  CAREER OPPORTUNITIES  |  INFORMATION FOR PATIENTS   |   RESEARCH COLLABORATIONS & BUSINESS DEVELOPMENT INQUIRIES

INFORMATION FOR INVESTORS

CAREER OPPORTUNITIES

INFORMATION FOR PATIENTS

RESEARCH COLLABORATIONS & BUSINESS DEVELOPMENT INQUIRIES

MAIL ICON  info@bonus-bio.com

MAIL ICON  +972 (0)73 206 7104

MAIL ICONMatam Advanced Technology
Park P.O.B 15143 Haifa 31905 Israel

you tube linkedin facebook twitter

© 2022 Bonus BioGroup Ltd. Created By Netron Israel Ltd

Please publish modules in offcanvas position.